Peter Slavin, with an emphasis on technology evaluation, adoption, and promotion. Following her tenure as a medical resident at Mass General, Christiana undertook an administrative fellowship under the guidance of Dr. She completed her residency at Mass General in Internal Medicine in 2005. Named Senior Director of the Accelerator in the summer of 2022, Christiana Iyasere, MD, MBA, brings over 15 years of experience developing early-stage technologies from academic medical institutions.Ĭhristiana is a graduate of Yale University and Columbia University College of Physicians and Surgeons. Emy holds a PhD from Harvard University in Molecular and Cellular Biology, a BA from the University of California-Berkeley in Molecular and Cell Biology, and is a registered patent agent with the United States Patent and Trademark Office (USPTO). Prior to joining Dana-Farber, Emy was Director of Licensing at Mass General Brigham Innovation, where she spent 13 years supporting investigators and building relationships with biotech and pharma companies, primarily for innovators in the disciplines of medicine, neuroscience, and dermatology. A primary focus for her role is to continuously refine and optimize the Innovation team's ability to provide excellent partnership and collaboration with clinicians and research scientists at Dana-Farber, and to catalyze and sustain relationships with external stakeholders in industry in order to bring new discoveries from the labs at Dana-Farber to patients. She has oversight over the Innovations Licensing, Research Contracts, Compliance, and Finance functions of the Robert and Renee Belfer Office for Dana-Farber Innovations (BODFI). Tolikas holds a BEng degree in Electrical and Electronics Engineering from the University of Glasgow, Scotland, MSc and PhD degrees in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology (MIT), and an MBA from the Sloan School of Management at MIT.Įmy Chen, PhD, is Vice President of Innovation at Dana-Farber Cancer Institute. At Harvard, she also served as Executive Director for Special Projects in the Office of the Provost, and was co-instructor in the Master in Design Engineering Program, offered by the Harvard School of Engineering & Applied Science and the Harvard Graduate School of Design.ĭr. Tolikas also played a central role in the launch and growth of the Wyss Institute for Biologically Inspired Engineering at Harvard University, where she spent nearly 10 years on the leadership team as Operations Director. Prior to joining Dana-Farber, she was CEO of the Wyss Center for Bio and Neuroengineering in Geneva, Switzerland, where she led the Center with a focus on the development and commercialization of a wide range of neurotechnologies.ĭr. Tolikas has more than two decades of experience in establishing and growing technology-based organizations in both industry and academia. Mary Tolikas, PhD, MSc, MBA, joined Dana-Farber in 2022. Senior Vice President and Chief Innovation Officer
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |